Resmetirom, sold under the brand name Rezdiffra, is a medication used for the treatment of noncirrhotic nonalcoholic steatohepatitis. It is a thyroid hormone receptor beta agonist.
The most common side effects include diarrhea and nausea.
Resmetirom was approved for medical use in the United States in March 2024. From Wikipedia
